Company profile
Home Page - Monument TX
Monument Therapeutics Limited is a UK company with status active founded in 2019 based in North West England.
Financial period: 1 Jan 2025 to 30 Jun 2025
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
CS01 | Transaction MzQ1NTk4NDU0M2FkaXF6a2N4
Published 21 Feb 2025 01:07
CS01 | Transaction MzQ0MzU0NDI3NGFkaXF6a2N4
Published 15 Nov 2024 10:21
SH01 | Transaction MzQ0MjY0MjE4MWFkaXF6a2N4
Published 11 Nov 2024 12:58
TM01 | Transaction MzQ0MjYzOTU2OGFkaXF6a2N4
Published 11 Nov 2024 12:36
RESOLUTIONS | Transaction WURFQ0NRRlRhZGlxemtjeA | Paper/PDF filed
Published 02 Nov 2024 07:32
MA | Transaction MzQ0MDY3NzA4NmFkaXF6a2N4 | Paper/PDF filed
Published 05 Nov 2024 07:26
TM01 | Transaction MzQ0MDY3NzU1NWFkaXF6a2N4
Published 23 Oct 2024 12:37
AP01 | Transaction MzQ0MDY3NzI1OWFkaXF6a2N4
Published 23 Oct 2024 12:34
AP01 | Transaction MzQ0MDY3Njk5M2FkaXF6a2N4
Published 23 Oct 2024 12:32
Company registered at Companies House
1 May 2024 to 31 May 2025
Disorders such as schizophrenia affect 1.5% of the population across the world and are lifelong, disabling illnesses. Whilst schizophrenia affects a smaller proportion of the global population than for example, depression, the global burden of disease is estimated to be the highest among the mental health disorders and with annual costs greater than those...
1 Nov 2020 to 30 Apr 2022
Over recent years it has become clear that inflammation in the brain may be a key factor contributing to many psychiatric and neurological conditions such as Alzheimer's disease and depression. Unfortunately, standard anti-inflammatory drugs such as ibruprofen do not help, because the way they are formulated stops them from being able to get into the brai...
